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Immunohistochemistry and computer assisted image analysis were used to examine the age-related changes in tyrosine hydroxy-
lase- (TH-) immunoreactivity in substantia nigra (SN), ventral tegmental area (VTA), locus ceruleus (LC) and dopamine-beta- 
hyroxylase- (DBH-) immunoreactivity in LC and subceruleus nuclei of the rat. The findings in 3-month-old rats were compared
with 28-month-old rats. In SN TH-positive neurons were concentrated in pars compacta and to a lesser extent - in pars lateralis. 
In VTA the TH-positive neurons were present over the entire area. In LC the immunoreactive perikarya were densely arranged 
and superimposed, but in subceruleus nuclei they were less numerous and individual cells were clearly discernible. The DBH-
immunoreaction distinctly demonstrated the noradrenergic LC and subceruleus neurons. The results indicate of only subtle signs 
of cell loss in the dopaminergic neuronal population of SN and VTA, whilst the cell loss of the noradrenergic neurons in LC and 
subceruleus nuclei is evident. On the other hand, considerable age-related dendritic alterations were observed in all catechol-
aminergic nuclei. Cross-sectional area and optical density (OD) of the TH-immunoreactive neurons in SN, VTA and LC, and of 
the DBH-immunoreactive neurons in LC and subceruleus nuclei were investigated. In aging the cross-sectional area decreased 
statistically and OD of the neurons in SN decreased with 13%. In VTA the cross-sectional area did not change its dimensions, 
while the OD increased with 19%. In LC and subceruleus nuclei the cross-sectional area decreased with 36% and the OD of the 
neurons decreased with 16%. In conclusion, the most resistant to age-related changes catecholaminergic region in the rat is the 
VTA, followed by the pars compacta of SN. Rodent LC is a very vulnerable region. Biomed Rev 2007; 18: 45-58.
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INTRODUCTION
Aging is often accompanied by behavioral changes, such as 
impaired memory, alterations in motor coordination, reduced 
sensory acuity, sleep pattern changes. Such alterations corre-
spond to neurodegenerative disorders in man occurring with 
aging, such as Parkinson’s disease and Alzheimer’s disease. 
In the catecholaminergic nuclei of the brainstem several cel-
lular markers have been characterized such as changes in the 
neuromelanin content, lipofuscin accumulation, appearance of 
neurofibrillary tangles, Lewy and Marinesco bodies, reduced
neuronal density (necrotic and/or apoptotic cell loss), changes 
in neuronal arborization, increased populations of glial cells, as 
well as more recently described diverse neurochemical factors, 
associated with normal aging and neurodegenerative diseases 
(neurotransmitter changes, tau protein, alpha-synuclein, iron, 
free radicals, calcium-binding proteins, neurotrophic fac-
tors). These classic and recent markers have been discussed 
in numerous articles and reviews (1-30); for comprehensive 
reviews see (31-35).  
 Substantia nigra (SN) and ventral tegmental area (VTA) 
contain the major dopaminergic neuronal groups in the brain-
stem and are reliably demonstrated by immunoreaction for the 
enzyme tyrosine hydroxylase (TH). The TH is a rate-limiting 
enzyme for dopamine synthesis, therefore, immunohistochem-
istry for TH can be used as a marker of dopaminergic neuronal 
alterations in these regions, especially in the brains of lower 
mammals that lack neuromelanin in the catecholaminergic 
neurons (reviewed in 34). Immunohistochemical investigations 
of the TH-immunoreactive neurons during aging in humans 
and different animal species have so far yielded controversial 
results. There are data on age-related changes of density of the 
TH-immunoreactive neurons (11,36-43), changes of TH-activ-
ity (29,44-46), changes of TH mRNA activity (38, 47), and 
changes in the dopamine content of the cells (37,44,48-52).
 The LC and subceruleus nuclei (dorsal and ventral) attracted 
much attention in the recent decades and there is a considerable 
body of literature, reporting a decrease of the neuron number 
with advancing age (4,53-56). In most studies neuromelanin 
was used as a marker of noradrenergic neurons, and some 
studies have additionally used immunohistochemical staining 
with antibody against TH (56-59), or against dopamine-beta-
hydroxylase (DBH) (58-60).  
 We investigated qualitatively and quantitatively the changes 
in the morphological appearance, cross-sectional area and opti-
cal density (OD) of the TH-immunoreactive neurons in SN, 
VTA, LC, and of DBH-immunoreactive neurons in LC and 
subceruleus nuclei during aging in rats. A preliminary report 
was presented (61).
 We analyzed young (3-months-old) and aged (28-months-old) 
Wistar rats by staining their brains under standard immuno-
histochemical protocols (62) with antibodies directed against 
TH and DBH. For reconstruction of the investigated nuclei 
tissue sections were arranged according to the stereotaxic atlas 
of Paxinos and Watson (63). Subsequent image analysis was 
performed qualitatively and quantitatively by measuring and 
comparison of cross-sectional area and optical density (OD) 
of positive neurons. Quantitative analysis was performed on 
an image analysis system consisting of Jenaval photomicro-
scope, Hitachi videocamera, IBM computer and appropriate 
software. Every positive neuron was measured and the calcula-
tion was made as follows: the mean value of the area surface 
of the neurons in the young animals was accepted as 100%. 
The OD of the cell bodies was expressed on an arbitrary scale 
ranging from 0 to 256 (0 – absolutely black, 256 – the OD of 
the adjacent glass outside of the section). The results obtained 
were statistically processed using Student’s t-test and mean 
± standard error of the area surface and OD were calculated. 
Statistical significance was accepted at p<0.05. 
Qualitative data
In the SN of young (control) rats, the TH-immunoreactive 
neurons were densely arranged in pars compacta (Fig. 1a) and 
a lower number was found in pars lateralis, while in pars re-
ticulata only a few immunopositive cells were observed. In the 
VTA the TH-immunoreactive cells were distributed over the 
entire area, and were condensed in the rostral linear nucleus, 
the paranigral nucleus, and especially – in the interfascicular 
nucleus (Fig. 2a, c). In the LC the TH- and DBH-immunoreac-
tive neurons were extremely densely arranged (Fig. 3a, 4a), 
whilst in the dorsal and ventral subceruleus nuclei the cells 
were more loosely arranged and the individual immunoposi-
tive neurons were clearly outlined with Golgi silver impreg-
nation-like quality, especially by the DBH-immunolabeling 
(Fig. 4a, 5a, b). 
 The immunohistochemical reaction for TH and DBH re-
vealed that the reaction product was brownish, homogenous 
and filled the entire perikaryon of the labeled neurons. As a
rule, it extended in the dendrites and axons of the catecho-
laminergic neurons. No reaction product was found in the 
neuronal nuclei. 
 In SN and VTA of young animals the TH-immunoreactive 
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neurons in VTA (Fig. 6b) did not changed their dimensions 
during aging, 516±12 versus 513±11 µm2 (p>0.05).  OD meas-
urements of the TH-positive perikarya indicated that in SN 
OD decreased significantly with 12% (Fig. 6d), from 95±1.7
to 127±1.4 (p<0.001). In VTA the OD increased significantly
in aging (Fig. 6e), from 134±1.4 to 84±1.2 (p<0.001). The OD 
increased with 19%. The morphometric study demonstrated 
that the cross-sectional area of the DBH-positive neurons in LC 
and subceruleus nuclei (Fig. 6c) decreased significantly with
36% in aging from 423±11.1 in 3-month-old rats to 271±7.5 
sq µm (p<0.001) in old rats. OD of the DBH-immunoreactive 
neurons in the subceruleus nuclei (Fig. 6f) of the 3-month-old 
rats was 51±1.5 (p<0.001) but in aged rats it decreased with 
42% to 165±1.2 (p<0.001, n=100). 
Comparison of our results with the data available
The most characteristic neuropathologic feature of the Par-
kinson’s disease is the both prominent and selective neuronal 
cell loss of the pigmented (dopaminergic) neurons of the SN 
pars compacta (1,9,11,17,32-34,64,65). The observations on 
the age alterations of SN in humans and experimental animals 
are less straightforward. Mann and Yates (2,3) demonstrated 
that a gradual decline takes place from 60 to 90 years in all 
neuromelanin-containing nuclei, and especially – in SN. The 
number of pigmented SN neurons (2,3,9,20,66,67) was re-
ported to progressively decrease. In 36 control cases ranged 
in age from 21 to 91 years, Fearnley and Lees (9) reported a 
decline of 4.7% per decade, and the total decrease reached 
33%. There was a significant sparing of the ventrolateral and
ventrointermediate neuronal groups in SN pars compacta – 
15% cell loss. Interestingly, the same neuronal groups are most 
severely affected by idiopathic Parkinson’s disease (1,9,32,65). 
Faraldi et al (15) supported the hypothesis that the overload of 
neuromelanin in advanced aging is neurotoxic and contributes 
to the cell loss in SN. Bannon and Whitty (40) reported up to 
75% loss of the dopamine transporter mRNA in older persons, 
but also noticed that the TH expression in the dopaminergic 
neurons was less affected. An age-related reduction in the 
number of SN dopamine transporter-immunoreactive neurons 
was established also by Ma et al (67). Chu et al (68) reported 
that in the human SN the number of both Nurr1- and TH-
immunoreactive neurons was mildly diminished already at 
middle age, and severely reduced in aged cases. Cabello et 
al (20) stated that the cell loss in the aged human SN may be 
compensated by hypertrophy. In contrast to the data discussed 
above, Kubis et al (41) provided unexpected results. They 
examined the human TH-immunostained neuronal population 
in SN, VTA and LC in 21 control subjects who died at ages 
44-110 years. They found no statistically significant cell loss
of TH-immunopositive neurons. 
Figure 6. Diagram showing the aging changes in cross-sectional area in µm2 of positive neurons in SN (a) and VTA (b) and OD 
in arbitrary units of TH-immunopositive neurons in SN (d), and VTA (e). (c) Changes in cross-sectional area  and (f) staining 





























Biomed Rev 18, 2007
Catecholaminergic neurons and aging
 The animal studies also provided somewhat diverse results. 
Irwin et al (39) examined young, intermediate-aged and old 
squirrel monkeys. Contrary to the obvious functional and 
neurochemical age-related changes (30-70% loss of dopamine 
in the neostriatum), the number of TH-immunoreactive cells 
did not significantly differ among the three age groups.  Pa-
kkenberg et al (52) examined the number of pigmented and 
nonpigmented SN neurons in young and old monkeys. They 
established that the total number of pigmented neurons was 
about eight times higher in old animals compared with young 
ones but the cell loss appeared to be minimal. Siddiqi and 
Peters (18) and Siddiqi et al (69) reported a SN and VTA cell 
loss in old rhesus monkey but, interestingly, they stated that 
the aging affects more significantly the small GABAergic in-
terneurons than the large dopaminergic projection neurons. Ac-
cording to Gerhardt et al (70), there are only modest (15-20%) 
declines of SN pars compacta TH-positive cells in the course 
of normal aging. McCormack et al. (43) found no significant
differences in the SN cell number in young, middle-aged 
and old squirrel monkeys, but pointed out also that there is a 
decrease of TH-immunoreactivity, paralleled with an increase 
of the neuromelanin content. Collier et al (46) reported that 
in rhesus monkeys the age-associated morphological changes 
include decline in the density of TH-positive fibers in stria-
tum, decreased SN soma size, and optical density of TH, but 
no significant loss of neurons. The differences in the normal
aging and neuropathology in the different neuronal groups in 
the human SN pars compacta is established (9; reviewed in 
34) but such a delineation was reported in monkeys only very 
recently. Kanaan et al (29) investigated young, middle-aged 
and old rhesus monkeys. They found out that the TH-positive 
neuron numbers were inversely correlated with advancing 
age specifically in the ventral tier of the SN pars compacta,
not in the dorsal tier or in the VTA. TH intensity decreased 
throughout the ventral midbrain with increasing age, an effect 
exacerbated in the ventral tier of SN pars compacta. Uchida 
et al (42) established that the TH-positive neurons in SN of 
old dogs appear to be well preserved but they found also 
cytological alterations typical for the human neuropathology. 
Tatton et al (36) and Greenwood et al (51) investigated the SN 
and LC in C57B1 mice aged 8 to 104 weeks, and found that 
the neuronal loss was due to neuronal death rather than loss 
of TH-immunoreactivity. The cytoplasmic TH was increased 
by 63% in 104-week-old mice in comparison to 8-week-old 
animals (51). McNeill et al (48,49) investigated the SN in 
young and aged C57B1/6N Nia mice. They found a progres-
sive accumulation of cytoplasmic lipofuscin granules and a 
markedly reduced dopamine content per cell as determined 
by histofluorescence. Further, McNeill and Koek (50) inves-
tigated six age groups (3-30 months aged) of the same mouse 
strain, and reported a small decline (11%) in the total number 
of dopaminergic neurons of the SN with age, a decrease not 
reaching a statistical significance. Emerich et al (37) postu-
lated that there are no reductions in number, area and length 
of TH-immunoreactive neurons in A8, A9 and A10 regions of 
24-25-month-old rats. Schuligoi et al (38) suggested that the 
reduction in TH mRNA in the VTA and SN pars compacta in 
33-month-old Sprague-Dawley rats is not due to a loss of TH 
mRNA expressing cells but due to a reduction in the hybridiza-
tion signal per expressing cell. Himi et al (47) investigated the 
expression of mRNAs encoding the dopamine transporter and 
TH in SN of young and aged Fischer 344 rats. They found that 
dopamine transporter mRNA decreases by 18 months, whilst 
TH mRNA reduction does not occur until 24 months. In the 
same rat strain the dopaminergic neurons exhibited increased 
axonal branching between 6 and 24 months (71). De la Cruz 
et al (45) report a significant decrease (55%) of TH activity in
rats between 12 and 24 months of age, while others established 
that in old mice the number of SN dopaminergic neurons was 
decreased by 10% in contrast to TH-immunodensity which 
was 24±3% higher compared to young animals (24). Recently, 
Cruz-Muros et al (72) compared the nigrostriatal and mesolim-
bic (e.g. – the VTA fiber system ascending to limbic forebrain
targets) in rats and suggested that both the nigrostriatal and the 
mesolimbic systems are vulnerable to aging, but in contrast to 
what occurs in Parkinson’s disease, the mesolimbic system is 
more vulnerable to aging than the nigrostriatal ones.      
 Due to the very uneven distribuition of the TH-immuno-
reactive neurons in VTA, we attempted a comparison of the 
neuronal number of labeled cells only in SN pars compacta. 
The results were nearly negative (a decrease of 1.5-3.5% by 
the old rats). Thus, our data are even lower than reported by 
McNeill and Koek (50), who found a decline of 11%, and 
declared that it does not reach a statistical significance. The
observation of SN pars compacta suggested only mild atrophic 
changes of the TH-positive neuronal perikarya. The morpho-
metric study, however, demonstrated that the cross sectional 
area of the positive neurons decreased with 28%. A decreased 
SN soma size without a cell loss was also reported in monkeys 
(46). In VTA the cross sectional area did not change. Such a 
discrepancy between SN and VTA dopaminergic neurons was 
not observed by Emerich et al (37). They declared that none of 
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the midbrain dopaminergic groups show area reduction of the 
TH-positive neurons. It is hard to explain the aging stability of 
the VTA neurons compared with the SN ones. Our results run 
counter to the data presented by Cruz-Muros et al (72), who 
reported findings contrary to ours – the VTA neurons are more
vulnerable to aging than the SN cells. In the human brain the 
cell loss in the aged SN may be compensated by hypertrophy 
(20) but apparently this phenomenon is absent in the rodent 
SN. Our data suggest that the OD of TH-positive perikarya 
in SN decreased with 12% in aged rats. Kanaan et al (29) 
also found a reduction in the TH activity in SN, especially 
prominent in the ventral tier of pars compacta in monkeys. 
Strangely, we found that in VTA the OD increased in old rats 
with 19% - another difference between the nigrostriatal and 
mesolimbic neuronal population in the mesencephalon. The 
VTA dopaminergic neurons are not only resistant to atrophic 
changes but also display an increased TH activity. A significant
increase of the TH activity was reported also by Greenwood 
et al (51) but this appears to be a compensation of unusually 
strong cell loss, reported by these authors. Very similar results 
were reported by Kim et al (24).
 With few exceptions (41,73), the investigators agree that 
with advancing age there is a decrease in number of LC neu-
rons in man (4,34,53-56,58-60,74,75). The data in rodents 
are somewhat contradictory but probably this is also due to 
the different strains examined. Goldman and Coleman (76) 
reported that in LC of Fischer 344 rats of ages from 12 to 32 
months there is no neuronal cell loss with advancing age. On 
the other hand, Sturrock and Rao (77) found a 47% decrease 
in Nissl-stained LC neurons in 31-month-old mice, compared 
to 6- and 15-month-old mice. Shores et al (78) found a LC cell 
loss in Brown-Norway rats but also reported an increase of TH 
mRNA which may potentially increase noradrenaline synthesis 
in the remaining neurons. Also, Tatton et al (44) counted im-
mediately adjacent TH-immunoreacted and Nissl-stained sec-
tions through the LC in mice at different ages, and concluded 
that the neuronal loss was due to neuronal death rather than 
loss of TH immunoreactivity. The present results indicate the 
occurrence of a significant cell loss in the LC of aged Wistar
rats, although not as dramatic as declared by Sturrock and 
Rao (77). The cell loss was predominantly localized in the 
ventral and lateral portions of the LC, and the dendritic radia-
tion within surrounding structures was significantly reduced.
In the subceruleus nuclei the cell loss was also prominent. In 
two out of four cases (one of them demonstrated on Fig. 4) 
the “alpha part” of the dorsal nucleus subceruleus was literally 
erased. The cell loss in the ventral subceruleus nucleus was also 
massive and was accompanied by a complete degeneration of 
the intrinsic plexus of noradrenergic axons. We investigated 
the cross-sectional area and the OD mainly in the subceruleus 
nuclei since the superimposition of the labeled neurons in LC 
obscured the detailed visualization of individual neurons. Ac-
cording to the present results the cross-sectional area in the 
DBH immunoreactive neurons decreased with 36%. These data 
were averaged. As seen in Figures 5b and 5d, some neurons 
undergo even more severe atrophic changes. The OD according 
to the present data decreased dramatically in aging – with 42%. 
It is not easily detectable by the observation of the neuronal 
perikarya but the pale appearance of the dendrites on Figure 
5d supports the validity of the OD measurement.
 All catecholaminergic neuronal groups presently examined 
exhibited heavy alterations in the dendritic and axonal arbori-
zation by advanced aging. A common finding was the den-
dritic loss, accompanied by distorted and thickened dendritic 
stumps. This phenomenon appears to be common throughout 
the phylogenetic scale, since similar changes were reported 
also by Cruz-Sanchez et al (79). They applied detailed trac-
ing of Golgi stained neurons in the SN of 20 human control 
brains ranging from 20 to 93 years of age. Cruz-Sanchez et 
al (79) encountered distorted profile of the cell body, loss of
dendrites and dendritic spines, and swelling and beading of the 
dendritic branches mainly in the oldest group (70-93 years). 
Heavy dendritic alterations are also present in aging noncate-
cholaminergic neuronal populations producing nitric oxide: the 
cholinergic neurons of the pedunculopontine and laterodorsal 
tegmental nucleus (80), and the neurons of the dorsolateral 
column of the periaqueductal gray (81). Finally, von Bohlen 
und Halbach et al (82) reported a significant decrease in spine
number of CA1 dendrites of the aged murine hippocampus that 
are clearly related to the memory and cognitive impairment. 
Thus, the obvious alterations of the dendritic tree appear to be 
a universal phenomenon for different neuronal populations, in 
different species.
CONCLUSION
There were only subtle signs of cell loss in the dopaminergic 
neuronal population of SN and VTA in aging, whereas the 
cell loss of the noradrenergic neurons in LC and subceruleus 
nuclei was evident. Considerable age-related dendritic altera-
tions were observed in all catecholaminergic nuclei. In aging, 
the cross-sectional area decreased statistically and OD of the 
neurons in SN diminished with 13%. In VTA, the neuronal 
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cross-sectional area did not change its dimensions, while the 
OD increased with 19%. In LC and subceruleus nuclei, the 
cross-sectional area decreased with 36% and the OD of the 
neurons decreased with 16%. The most resistant to age-re-
lated changes catecholaminergic region in the rat is the VTA, 
followed by the pars compacta of SN, while the rodent LC 
appears to be a very vulnerable region.
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